{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:33:06Z","timestamp":1791282786227,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,20]],"date-time":"2009-12-20T00:00:00Z","timestamp":1261267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,20]],"date-time":"2009-12-20T00:00:00Z","timestamp":1261267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/nm.2071","type":"journal-article","created":{"date-parts":[[2009,12,20]],"date-time":"2009-12-20T21:57:18Z","timestamp":1261346238000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":292,"title":["Generation of stable monoclonal antibody\u2013producing B cell receptor\u2013positive human memory B cells by genetic programming"],"prefix":"10.1038","volume":"16","author":[{"given":"Mark J","family":"Kwakkenbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen Q","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M M","family":"van Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl V","family":"Lukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grada M","family":"van Bleek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra N","family":"Widjojoatmodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy M J M","family":"Bogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc A","family":"Scheeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,20]]},"reference":[{"key":"BFnm2071_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1126\/science.1702555","volume":"251","author":"J Banchereau","year":"1991","unstructured":"Banchereau, J., de Paoli, P., Valle, A., Garcia, E. & Rousset, F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251, 70\u201372 (1991).","journal-title":"Science"},{"key":"BFnm2071_CR2","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1084\/jem.193.12.1373","volume":"193","author":"CH Kim","year":"2001","unstructured":"Kim, C.H. et al. Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J. Exp. Med. 193, 1373\u20131381 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm2071_CR3","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.4049\/jimmunol.177.8.5236","volume":"177","author":"KL Good","year":"2006","unstructured":"Good, K.L., Bryant, V.L. & Tangye, S.G. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177, 5236\u20135247 (2006).","journal-title":"J. Immunol."},{"key":"BFnm2071_CR4","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","volume":"175","author":"R Ettinger","year":"2005","unstructured":"Ettinger, R. et al. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175, 7867\u20137879 (2005).","journal-title":"J. Immunol."},{"key":"BFnm2071_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.20062104","volume":"204","author":"TC Kuo","year":"2007","unstructured":"Kuo, T.C. et al. Repression of Bcl-6 is required for the formation of human memory B cells in vitro. J. Exp. Med. 204, 819\u2013830 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnm2071_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","volume":"19","author":"M Shapiro-Shelef","year":"2003","unstructured":"Shapiro-Shelef, M. et al. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19, 607\u2013620 (2003).","journal-title":"Immunity"},{"key":"BFnm2071_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1126\/science.276.5312.589","volume":"276","author":"AL Dent","year":"1997","unstructured":"Dent, A.L., Shaffer, A.L., Yu, X., Allman, D. & Staudt, L.M. Control of inflammation, cytokine expression, and germinal center formation by Bcl-6. Science 276, 589\u2013592 (1997).","journal-title":"Science"},{"key":"BFnm2071_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.186.3.439","volume":"186","author":"T Fukuda","year":"1997","unstructured":"Fukuda, T. et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186, 439\u2013448 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnm2071_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nature03147","volume":"432","author":"RT Phan","year":"2004","unstructured":"Phan, R.T. & Dalla-Favera, R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432, 635\u2013639 (2004).","journal-title":"Nature"},{"key":"BFnm2071_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nri1572","volume":"5","author":"M Shapiro-Shelef","year":"2005","unstructured":"Shapiro-Shelef, M. & Calame, K. Regulation of plasma-cell development. Nat. Rev. Immunol. 5, 230\u2013242 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm2071_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1101\/gad.929302","volume":"16","author":"A Shvarts","year":"2002","unstructured":"Shvarts, A. et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. Genes Dev. 16, 681\u2013686 (2002).","journal-title":"Genes Dev."},{"key":"BFnm2071_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ni1172","volume":"6","author":"FA Scheeren","year":"2005","unstructured":"Scheeren, F.A. et al. STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat. Immunol. 6, 303\u2013313 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnm2071_CR13","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.4049\/jimmunol.180.7.4805","volume":"180","author":"SA Diehl","year":"2008","unstructured":"Diehl, S.A. et al. STAT3-mediated up-regulation of BLIMP1 is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180, 4805\u20134815 (2008).","journal-title":"J. Immunol."},{"key":"BFnm2071_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1600-065X.1997.tb00963.x","volume":"156","author":"YJ Liu","year":"1997","unstructured":"Liu, Y.J. & Arpin, C. Germinal center development. Immunol. Rev. 156, 111\u2013126 (1997).","journal-title":"Immunol. Rev."},{"key":"BFnm2071_CR15","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro, H. & Clark, E.A. Regulation of B cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2, 945\u2013956 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm2071_CR16","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","volume":"179","author":"VL Bryant","year":"2007","unstructured":"Bryant, V.L. et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179, 8180\u20138190 (2007).","journal-title":"J. Immunol."},{"key":"BFnm2071_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","volume":"360","author":"CB Hall","year":"2009","unstructured":"Hall, C.B. et al. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360, 588\u2013598 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnm2071_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1086\/314846","volume":"180","author":"S Johnson","year":"1999","unstructured":"Johnson, S. et al. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9. J. Infect. Dis. 180, 35\u201340 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFnm2071_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.antiviral.2006.05.014","volume":"71","author":"RW Sidwell","year":"2006","unstructured":"Sidwell, R.W. & Barnard, D.L. Respiratory syncytial virus infections: recent prospects for control. Antiviral Res. 71, 379\u2013390 (2006).","journal-title":"Antiviral Res."},{"key":"BFnm2071_CR20","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.1097\/01.inf.0000144672.81955.a4","volume":"23","author":"JB Domachowske","year":"2004","unstructured":"Domachowske, J.B., Bonville, C.A. & Rosenberg, H.F. Animal models for studying respiratory syncytial virus infection and its long term effects on lung function. Pediatr. Infect. Dis. J. 23, S228\u2013S234 (2004).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"BFnm2071_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.immunol.26.021607.090236","volume":"26","author":"JU Peled","year":"2008","unstructured":"Peled, J.U. et al. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26, 481\u2013511 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm2071_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/ni923","volume":"4","author":"CE Sayegh","year":"2003","unstructured":"Sayegh, C.E., Quong, M.W., Agata, Y. & Murre, C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4, 586\u2013593 (2003).","journal-title":"Nat. Immunol."},{"key":"BFnm2071_CR23","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.4049\/jimmunol.166.6.3659","volume":"166","author":"C Dong","year":"2001","unstructured":"Dong, C., Temann, U.A. & Flavell, R.A. Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166, 3659\u20133662 (2001).","journal-title":"J. Immunol."},{"key":"BFnm2071_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/ni1086","volume":"5","author":"R Shinkura","year":"2004","unstructured":"Shinkura, R. et al. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5, 707\u2013712 (2004).","journal-title":"Nat. Immunol."},{"key":"BFnm2071_CR25","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1084\/jem.20081319","volume":"205","author":"KM McBride","year":"2008","unstructured":"McBride, K.M. et al. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 205, 2585\u20132594 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnm2071_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm1080","volume":"10","author":"E Traggiai","year":"2004","unstructured":"Traggiai, E. et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10, 871\u2013875 (2004).","journal-title":"Nat. Med."},{"key":"BFnm2071_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1074-7613(01)00089-9","volume":"14","author":"ML Dykstra","year":"2001","unstructured":"Dykstra, M.L., Longnecker, R. & Pierce, S.K. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity 14, 57\u201367 (2001).","journal-title":"Immunity"},{"key":"BFnm2071_CR28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","volume":"453","author":"J Wrammert","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\u2013671 (2008).","journal-title":"Nature"},{"key":"BFnm2071_CR29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nbt0808-886","volume":"26","author":"MB Zwick","year":"2008","unstructured":"Zwick, M.B., Gach, J.S. & Burton, D.R. A welcome burst of human antibodies. Nat. Biotechnol. 26, 886\u2013887 (2008).","journal-title":"Nat. Biotechnol."},{"key":"BFnm2071_CR30","first-page":"1241","volume":"34","author":"F Deinhardt","year":"1974","unstructured":"Deinhardt, F., Falk, L.A. & Wolfe, L.G. Transformation of nonhuman primate lymphocytes by Epstein-Barr virus. Cancer Res. 34, 1241\u20131244 (1974).","journal-title":"Cancer Res."},{"key":"BFnm2071_CR31","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1182\/blood.V94.8.2637.420k22_2637_2646","volume":"94","author":"AC Jaleco","year":"1999","unstructured":"Jaleco, A.C. et al. Genetic modification of human B cell development: B cell development is inhibited by the dominant negative helix loop helix factor Id3. Blood 94, 2637\u20132646 (1999).","journal-title":"Blood"},{"key":"BFnm2071_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/cimm.1999.1520","volume":"195","author":"MH Heemskerk","year":"1999","unstructured":"Heemskerk, M.H. et al. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells. Cell. Immunol. 195, 10\u201317 (1999).","journal-title":"Cell. Immunol."},{"key":"BFnm2071_CR33","first-page":"3894","volume":"63","author":"LA Smit","year":"2003","unstructured":"Smit, L.A. et al. Expression of activation-induced cytidine deaminase is confined to B cell non-Hodgkin\u2032s lymphomas of germinal-center phenotype. Cancer Res. 63, 3894\u20133898 (2003).","journal-title":"Cancer Res."},{"key":"BFnm2071_CR34","first-page":"1385","volume":"79","author":"GA Prince","year":"1999","unstructured":"Prince, G.A., Prieels, J.P., Slaoui, M. & Porter, D.D. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Lab. Invest. 79, 1385\u20131392 (1999).","journal-title":"Lab. Invest."}],"updated-by":[{"DOI":"10.1038\/nm1216-1502a","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T00:00:00Z","timestamp":1480982400000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2071","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:24:49Z","timestamp":1684434289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,20]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFnm2071"],"URL":"https:\/\/doi.org\/10.1038\/nm.2071","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12109958.13258057","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,20]]},"assertion":[{"value":"18 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2016","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Corrigendum","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the article did not mention some restrictions on the availability of reagents. Please note that the retroviral vectors containing BCL-6 and BCL-xL have been generated by a for-profit company, AIMM Therapeutics, which makes the plasmids available. Obtaining the plasmids requires an MTA (\n                      \n                      ) that includes financial obligations.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A.D., F.A.S., E.Y., M.J.K., H.S. and T.B. are listed on patent applications (international patent PCT\/NL2008\/050333 entitled 'RSV specific binding molecules and means for producing them' and PCT\/NL2005\/000848 'Means and methods for influencing the stability of cells' (to the patent offices of Japan, the US, Brazil, Canada, Europe, Australia and New Zealand) describing the RSV-specific antibodies and describing the B cell immortalization technology using Bcl-6 and Bcl-xL technology. M.J.K., E.Y., A.Q.B., C.M.M.v.G., T.B. and H.S. are employees of AIMM Therapeutics. H.S. has personal financial interests in AIMM Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}